Abstract
Thirteen difluoromethyl-containing pseudopeptides were synthesized by Ugi reaction using the novel building block 2,2-difluoro-2-(phenylthio)acetic acid (2) as one component, followed by removal of the phenylsulfanyl protecting group in the presence of tributyltin hydride and azobisisobutyronitrile.
Keywords: difluoromethyl functionality, gem-difluoromethylene-containing acid, pseudopeptides, reductive cleavage, Ugi reaction
Introduction
Fluorinated amino acids and pseudopeptides have increasingly attracted attention in recent years [1–5]. The selective incorporation of fluorine-containing groups, such as trifluoromethyl, difluoromethyl and difluoromethylene, into peptides or peptidomimetics often drastically alters the chemical, physical, and biological properties of the parent compounds [6–9]. Nowadays, difluoromethyl-containing compounds are increasingly being applied in pharmaceuticals and agrochemicals [10–12]. It is reported that difluoromethyl functionality (CF2H) is isosteric and isopolar to the hydroxyl group and can behave as a hydrogen donor through hydrogen bonding [13].
However, to date, most fluorine-containing peptide modifications involve the introduction of trifluoromethyl or difluoromethylene into molecules [14–18]. Only a few examples have been reported of the preparation and bioassay of pseudopeptides and peptidomimetics bearing difluoromethyl groups. For example, compound I can act as bradykinin B1 antagonist or inverse agonist and can be used in the prevention of inflammation and pain [19]. Compound II is an inhibitor of microsomal triglyceride transfer protein (MTP) and useful for the treatment of obesity and atherosclerosis (Figure 1) [20].
Figure 1.
Two examples of bioactive pseudopeptides bearing a CF2H group.
Among the protocols for the preparation of pseudopeptide derivatives, the Ugi four-component reaction offers significant advantages over conventional linear-step synthesis [21]. Various fluorinated building blocks have been used in the Ugi four-component reaction to construct a fluorinated compound library [22–25]. Our group has always been interested in developing efficient methods for the preparation of difluoromethyl-containing compounds through multicomponent reactions [26–30]. Recently, we reported a novel and general strategy for the construction of a difluoromethyl compound library, and we further illustrated this strategy by application to the synthesis of CF2H-bearing pseudopeptides and 1,2,3-triazoles through Ugi and click reaction, respectively [27,30]. In continuation of our interest in the synthesis of diverse difluoromethyl-containing pseudopeptides, we herein report a novel and efficient synthesis of difluoromethyl-containing pseudopeptides through Ugi reaction, with gem-difluoromethylene-containing acid as a key component, followed by reductive cleavage of the phenylsulfanyl group (Scheme 1).
Scheme 1.
Synthesis of difluoromethyl-containing pseudopeptides (4a–m) by Ugi reaction and desulfanylation.
Results and Discussion
For the purpose of screening novel bioactive compounds, we recently prepared a variety of diverse difluoromethyl-containing pseudopeptides. In our initial experiments, we tried to use difluoroacetic acid as one component to undergo Ugi reaction to prepare difluoromethyl-containing pseudopeptides. Unfortunately, the anticipated difluoromethyl-containing product 4a was not obtained (Scheme 2). Although there are a few examples of acetic acid and trifluoroacetic acid acting as substrates in an Ugi reaction [24,31], up to now, no literature was found concerning the use of difluoroacetic acid as one of the components in the Ugi reaction. For a comparative study, acetic acid and trifluoroacetic acid served as the substrates for the Ugi reaction under the same reaction conditions as those used for the difluoroacetic acid, and the results indicated that the reaction proceeded efficiently regardless of reaction conditions, and the Ugi products (5 and 6) were obtained in good yields. The hydrogen atom next to the CF2 group seems to influence the formation of Ugi product.
Scheme 2.
The Ugi reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with acetic acid, difluoroacetic acid and trifluoroacetic acid in methanol or under solvent-free conditions.
In previous studies, we developed a synthetic methodology to prepare functionalized small molecules having a CF2H group [27]. In this work, we first synthesized a protected difluoro-containing building block, 2,2-difluoro-2-(phenylthio)acetic acid (2). The synthesis of compound 2 is illustrated in Scheme 3. The ethyl 2,2-difluoro-2-(phenylthio)acetate (1) was readily prepared by the reaction of ethyl bromodifluoroacetate and thiophenol according to the known procedure [32]. The novel difluorinated acid 2 was obtained by hydrolysis of the ester under basic condition in nearly quantitative yield.
Scheme 3.
Synthesis of 2,2-difluoro-2-(phenylthio)acetic acid (2).
After successful synthesis of the protected functionalized CF2 building block 2, we tried to use it as one of the components in the preparations of the difluoromethylene-containing pseudopeptides by Ugi reaction. Indeed, the reaction of aniline, benzaldehyde, (isocyanomethyl)benzene with 2 proceeded efficiently under solvent-free conditions. Finally, we removed the protecting group (PhS) with Bu3SnH/AIBN according to our previous research, and the desired difluoromethyl-containing pseudopeptide was successfully obtained [27].
To demonstrate the scope of the method, several different substituted anilines, substituted benzaldehydes, isocyanides and this novel difluorinated building block 2 were subjected to Ugi reaction under solvent-free conditions, followed by reductive cleavage of the phenylsulfanyl group. It was found that both Ugi reaction and desulfanylation proceeded smoothly for all substrates used to give the corresponding difluoromethylene-containing and difluoromethyl-containing pseudopeptides (3a–m and 4a–m) in good yields (Table 1).
Table 1.
Synthesis of difluoromethylene-containing pseudopeptides (3a–m) and difluoromethyl-containing pseudopeptides (4a–m).
![]() | |||||
| Entry | R1 | R2 | R3 | 3 | 4 |
| Yield (%)a | Yield (%)a | ||||
| a | Ph | Ph | Bn | 82 | 75 |
| b | 2-MePh | Ph | Bn | 78 | 68 |
| c | 2-MePh | 4-MePh | Bn | 75 | 74 |
| d | 4-MeOPh | Ph | Bn | 79 | 75 |
| e | Ph | 4-MeOPh | Bn | 78 | 70 |
| f | 2-MePh | 4-MeOPh | Bn | 74 | 67 |
| g | 4-MePh | 4-MeOPh | Bn | 72 | 78 |
| h | 4-FPh | 4-MeOPh | Bn | 70 | 71 |
| i | Ph | 4-FPh | Bn | 77 | 75 |
| j | 2-MePh | 4-FPh | Bn | 70 | 69 |
| k | 4-MeOPh | 4-FPh | Bn | 72 | 74 |
| l | Ph | Ph | Ph | 68 | 66 |
| m | Ph | 4-MeOPh | Ph | 66 | 60 |
aIsolated yield.
Conclusion
In summary, we have developed a novel and efficient protocol for the synthesis of CF2H-containing pseudopeptides by Ugi reaction of substituted anilines, benzaldehyde, isocyanides and the novel building block 2,2-difluoro-2-(phenylthio)acetic acid (2), followed by the cleavage of the phenylsulfanyl group.
Experimental
General
All reagents were of analytic grade, obtained from commercial suppliers and were used without further purification. Melting points were measured in an open capillary using Büchi melting point B-540 apparatus and are uncorrected. 1H NMR and 13C NMR spectra were recorded on a Bruker AM-400 spectrometer (400 MHz and 100 MHz, respectively) using TMS as internal standard. The 19F NMR were obtained using a Bruker AM-400 spectrometer (376 MHz) and the 19F NMR were measured with external CF3CO2H as standard. Gas chromatography-mass spectra (GC-MS) were recorded on HP 5973 MSD with 6890 GC. High resolution mass spectra (HRMS) were recorded under electron impact conditions using a MicroMass GCT CA 055 instrument and recorded on a MicroMass LCTTM spectrometer. Column chromatography was carried out with Merck 60 (230–400 mesh) silica gel.
General procedure for compounds 3a–m
To a stirred amine (1 mmol), the aldehyde (1 mmol) was added in portions for about 5 min. The mixture was stirred for 30 min at rt. Then, the reaction mixture was heated to 60 °C, and isocyanide (1 mmol) and 2,2-difluoro-2-(phenylthio)acetic acid (2) (1 mmol) were added. Stirring was continued at 60 °C for 1 h (TLC). The crude residue was purified by chromatography to give the desired products 3.
General procedure for compounds 4a–m
Bu3SnH (0.58 g, 2 mmol) was added under argon atmosphere to a solution of 3 (1 mmol) in dry toluene (3 mL). Deoxygenation was continued for 5 min. Azobisisobutyronitrile (AIBN) (0.02 g, 0.1 mmol) was added and the solution was heated at reflux for 9 h (TLC). The mixture was concentrated under reduced pressure and the residue was dissolved in EtOAc (5 mL). The solution was stirred with KF/H2O (15 mg/0.15 mL) for 3 h and extracted with EtOAc (3 × 20 mL). The combined organic phases were washed successively with water (20 mL) and brine (20 mL), and dried over anhydrous Na2SO4. After removal of the solvent, the crude product was purified by chromatography to give the desired products 4.
Supporting Information
Experimental procedures and compound characterization.
Acknowledgments
We are grateful for financial support from the National Natural Science Foundation of China (Grant No. 21072057), the National Basic Research Program of China (973 Program, 2010CB126101), the Shanghai Foundation of Science and Technology (09391911800) and the Shanghai Leading Academic Discipline Project (B507).
This article is part of the Thematic Series "Multicomponent reactions".
References
- 1.Qiu X, Meng W, Qing F. Tetrahedron. 2004;60:6711–6745. doi: 10.1016/j.tet.2004.05.051. [DOI] [Google Scholar]
- 2.Jäckel C, Koksch B. Eur J Org Chem. 2005:4483–4503. doi: 10.1002/ejoc.200500205. [DOI] [Google Scholar]
- 3.Meng H, Kumar K. J Am Chem Soc. 2007;129:15615–15622. doi: 10.1021/ja075373f. [DOI] [PubMed] [Google Scholar]
- 4.Couve-Bonnaire S, Cahard D, Pannecoucke X. Org Biomol Chem. 2007;5:1151–1157. doi: 10.1039/b701559c. [DOI] [PubMed] [Google Scholar]
- 5.Mlostoń G, Obijalska E, Heimgartner H. J Fluorine Chem. 2010;131:829–843. doi: 10.1016/j.jfluchem.2010.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zanda M. New J Chem. 2004;28:1401–1411. doi: 10.1039/B405955G. [DOI] [Google Scholar]
- 7.Giménez D, Andreu C, del Olmo M, Varea T, Diaz D, Asensio G. Bioorg Med Chem. 2006;14:6971–6978. doi: 10.1016/j.bmc.2006.06.027. [DOI] [PubMed] [Google Scholar]
- 8.Olimpieri F, Tambaro S, Fustero S, Lazzari P, Sanchez-Roselló M, Pani L, Volonterio A, Zanda M. Bioorg Med Chem Lett. 2009;19:4715–4719. doi: 10.1016/j.bmcl.2009.06.064. [DOI] [PubMed] [Google Scholar]
- 9.Kitamoto T, Marubayashi S, Yamazaki T. Tetrahedron. 2008;64:1888–1894. doi: 10.1016/j.tet.2007.11.085. [DOI] [Google Scholar]
- 10.Goure W F, Leschinsky K L, Wratten S J, Chupp J P. J Agric Food Chem. 1991;39:981–986. doi: 10.1021/jf00005a036. [DOI] [Google Scholar]
- 11.Ojima I, Lin S, Slater J C, Wang T, Pera P, Bernacki R J, Ferlini C, Scambia G. Bioorg Med Chem. 2000;8:1619–1628. doi: 10.1016/S0968-0896(00)00093-6. [DOI] [PubMed] [Google Scholar]
- 12.Ferreira S B, Costa M S, Boechat N, Bezerra R J S, Genestra M S, Canto-Cavalheiro M M, Kover W B, Ferreira V F. Eur J Med Chem. 2007;42:1388–1395. doi: 10.1016/j.ejmech.2007.02.020. [DOI] [PubMed] [Google Scholar]
- 13.Erickson J A, McLoughlin J I. J Org Chem. 1995;60:1626–1631. doi: 10.1021/jo00111a021. [DOI] [Google Scholar]
- 14.Formicola L, Maréchal X, Basse N, Bouvier-Durand M, Bonnet-Delpon D, Milcent T, Reboud-Ravaux M, Ongeri S. Bioorg Med Chem Lett. 2009;19:83–86. doi: 10.1016/j.bmcl.2008.11.012. [DOI] [PubMed] [Google Scholar]
- 15.Fustero S, Chiva G, Piera J, Sanz-Cervera J F, Volonterio A, Zanda M, Ramirez de Arellano C. J Org Chem. 2009;74:3122–3132. doi: 10.1021/jo9001867. [DOI] [PubMed] [Google Scholar]
- 16.Peng W, Zhao J, He P, Zhu S. Synlett. 2006:296–300. doi: 10.1055/s-2006-926225. [DOI] [Google Scholar]
- 17.Li G, van der Donk W A. Org Lett. 2007;9:41–44. doi: 10.1021/ol062401a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Bigotti S, Meille S V, Volonterio A, Zanda M. J Fluorine Chem. 2008;129:767–774. doi: 10.1016/j.jfluchem.2008.06.018. [DOI] [Google Scholar]
- 19.Bock M G, Feng D, Kuduk S, inventors. Aminocyclopropanecarboxamide derivatives as bradykinin antagonists. WO/2005/085198. Patent. 2005 Sep 15;
- 20.Bertinato P, Maddux T M, inventors. Microsomal triglyceride transfer protein inhibitors. WO/2004/056775. Patent. 2004 Jul 8;
- 21.Dömling A. Chem Rev. 2006;106:17–89. doi: 10.1021/cr0505728. [DOI] [PubMed] [Google Scholar]
- 22.Shibata N, Das B K, Takeuchi Y. J Chem Soc, Perkin Trans 1. 2000:4234–4236. doi: 10.1039/b007455l. [DOI] [Google Scholar]
- 23.Gouge V, Jubault P, Quirion J-C. Tetrahedron Lett. 2004;45:773–776. doi: 10.1016/j.tetlet.2003.11.019. [DOI] [Google Scholar]
- 24.Gulevich A V, Shevchenko N E, Balenkova E S, Röschenthaler G-V, Nenajdenko V G. Tetrahedron. 2008;64:11706–11712. doi: 10.1016/j.tet.2008.10.004. [DOI] [Google Scholar]
- 25.Wu J, Cao S. Curr Org Chem. 2009;13:1791–1804. doi: 10.2174/138527209789630460. [DOI] [Google Scholar]
- 26.Liu N, Cao S, Shen L, Wu J, Yu J, Zhang J, Li H, Qian X. Tetrahedron Lett. 2009;50:1982–1985. doi: 10.1016/j.tetlet.2009.02.056. [DOI] [Google Scholar]
- 27.Wu J, Cao S, Liu N, Shen L, Yu J, Zhang J, Li H, Qian X. Org Biomol Chem. 2010;8:2386–2391. doi: 10.1039/c000835d. [DOI] [PubMed] [Google Scholar]
- 28.Li H, Yu J, Cao S, Shen L, Wu M, Cheng J, Qian X. Sci China, Ser B: Chem. 2010;53:1509–1513. doi: 10.1007/s11426-010-4005-0. [DOI] [Google Scholar]
- 29.Wu M, Yu J, Zhao W, Wu J, Cao S. J Fluorine Chem. 2011;132:155–159. doi: 10.1016/j.jfluchem.2010.12.010. [DOI] [Google Scholar]
- 30.Zhang J, Wu J, Shen L, Jin G, Cao S. Adv Synth Catal. 2011;353:580–584. doi: 10.1002/adsc.201000791. [DOI] [Google Scholar]
- 31.Bouma M, Masson G, Zhu J. J Org Chem. 2010;75:2748–2751. doi: 10.1021/jo100302y. [DOI] [PubMed] [Google Scholar]
- 32.Eto H, Kaneko Y, Takeda S, Tokizawa M, Sato S, Yoshida K, Namiki S, Ogawa M, Maebashi K, Ishida K, et al. Chem Pharm Bull. 2001;49:173–182. doi: 10.1248/cpb.49.173. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Experimental procedures and compound characterization.





